Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare Biotechnology
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on... see more

CSE:QNTM - Post Discussion

Quantum BioPharma Ltd > Biotech analysis criteria run through
View:
Post by GrahamB on Feb 22, 2023 1:24pm

Biotech analysis criteria run through

 
Clinical trial data: Evaluate the results of the company's clinical trials. Are the results promising, and do they suggest that the product or technology has the potential to succeed in the market? Consider the stage of the trial and the number of patients enrolled.

Ok-they failed to complete the COVID PEA trial-heard nothing in followup on the steady state IBS trials-but the MD&A INDICATED essentially a write off

So human trials are a failure with FSD

We now have a mouse trial that was POC

There is no human data

Anyone else have thoughts here?
Comment by DavidRosenberg on Feb 22, 2023 1:41pm
They failed covid trials with 1 patient tested  = raza bokhari leadership he was ceo  cannabis venture failed = Thomas fairfull leadership he was the ceo of FV Pharma  lucid acquisition was done by none of the previous leadership roles now it's on current management to grow value  current management and leadership with real updates phase 2 trials currently recruitment ...more  
Quantum BioPharma Ltd